CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Planned sale Henn Matthew R sold 1,257 shares at $17.30 ($21,746)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 217 shares at $16.65 ($3,613)
- 4 Planned sale DesRosier Thomas sold 76 shares at $16.65 ($1,265)
- 4 Planned sale Henn Matthew R sold 73 shares at $16.65 ($1,215)
- 4 Planned sale Young Teresa L. sold 59 shares at $16.65 ($982)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Young Teresa L. sold 63 shares at $7.28 ($459)
- 4 Planned sale CEO and President sold 220 shares at $7.28 ($1,602)
- 4 Planned sale Chief Legal Officer and EVP sold 79 shares at $7.28 ($575)
- 4 Planned sale Henn Matthew R sold 77 shares at $7.28 ($561)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 19 · 380 filings